A detailed history of Two Sigma Investments, LP transactions in Ocugen, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 363,718 shares of OCGN stock, worth $363,718. This represents 0.0% of its overall portfolio holdings.

Number of Shares
363,718
Previous 363,483 0.06%
Holding current value
$363,718
Previous $563,000 36.06%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$0.98 - $1.95 $230 - $458
235 Added 0.06%
363,718 $360,000
Q2 2024

Aug 14, 2024

SELL
$1.18 - $1.98 $781,779 - $1.31 Million
-662,525 Reduced 64.57%
363,483 $563,000
Q1 2024

May 15, 2024

BUY
$0.5 - $1.83 $434,352 - $1.59 Million
868,704 Added 552.25%
1,026,008 $1.68 Million
Q4 2023

Feb 14, 2024

BUY
$0.36 - $0.57 $8,179 - $12,951
22,722 Added 16.88%
157,304 $89,000
Q3 2023

Nov 14, 2023

BUY
$0.4 - $0.62 $32,055 - $49,686
80,139 Added 147.2%
134,582 $53,000
Q2 2023

Aug 14, 2023

BUY
$0.45 - $0.88 $24,499 - $47,909
54,443 New
54,443 $29,000
Q4 2022

Feb 14, 2023

BUY
$1.11 - $1.87 $308,725 - $520,104
278,131 Added 202.61%
415,408 $540,000
Q3 2022

Nov 14, 2022

BUY
$1.75 - $3.1 $240,234 - $425,558
137,277 New
137,277 $244,000
Q3 2020

Nov 16, 2020

SELL
$0.2 - $0.72 $12,480 - $44,930
-62,404 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$0.22 - $0.46 $13,728 - $28,705
62,404 New
62,404 $14,000
Q1 2020

May 15, 2020

SELL
$0.26 - $0.73 $25,584 - $71,832
-98,400 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$0.27 - $2.19 $26,568 - $215,496
98,400 New
98,400 $51,000

Others Institutions Holding OCGN

About Ocugen, Inc.


  • Ticker OCGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,566,000
  • Market Cap $217M
  • Description
  • Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...
More about OCGN
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.